(Q44561676)

English

Plaque reduction neutralization test for measles antibodies: Description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccination

scientific article published on 12 November 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 December 2017

Plaque reduction neutralization test for measles antibodies: Description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccination (English)

1 reference

Europe PubMed Central

4 December 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

3

object named as

Nick Andrews

1 reference

Europe PubMed Central

4 December 2017

author name string

Bernard J Cohen

1

1 reference

Europe PubMed Central

4 December 2017

Susette Audet

2

1 reference

Europe PubMed Central

4 December 2017

Judy Beeler

4

1 reference

Europe PubMed Central

4 December 2017

WHO working group on measles plaque reduction neutralization test

5

1 reference

Europe PubMed Central

4 December 2017

language of work or name

0 references

publication date

12 November 2007

1 reference

Europe PubMed Central

4 December 2017

1 reference

Europe PubMed Central

4 December 2017

26

1 reference

Europe PubMed Central

4 December 2017

1

1 reference

Europe PubMed Central

4 December 2017

59-66

1 reference

Europe PubMed Central

4 December 2017

Global measles elimination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.046

7 January 2021

Role of virus strain dm conventional and enhanced measles plaque neutralization test

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.046

7 January 2021

Measles immunity testing: comparison of two measles IgG ELISAs with plaque reduction neutralisation assay.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.046

7 January 2021

The 1st International Standard for anti-measles serum.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.046

7 January 2021

Analysis of studies to evaluate immune response to combination vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.046

7 January 2021

Measles antibody: reevaluation of protective titers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.046

7 January 2021

Immunization of six-month-old infants with different doses of Edmonston-Zagreb and Schwarz measles vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.046

7 January 2021

Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.046

7 January 2021

Factors determining prevalence of maternal antibody to measles virus throughout infancy: a review

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.046

7 January 2021

A simplified and standardized neutralization enzyme immunoassay for the quantification of measles neutralizing antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.10.046

7 January 2021

Identifiers

10.1016/J.VACCINE.2007.10.046

1 reference

Europe PubMed Central

4 December 2017

1 reference

Europe PubMed Central

4 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44561676&oldid=2028126763"